Thomas Gaillard

8PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 07, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network.

|Jun 23, 2026
Association Between Axillary Surgical Management and Survival for Patients With De Novo Metastatic Breast Cancer.

|Jul 01, 2025
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.

Toulsie Ramtohul, Derek Lollivier, Justine Spriet

|Jan 27, 2024
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib.

Thomas Gaillard, Jeanne Piketty, Jean-Guillaume Feron

|Nov 12, 2021
Breast Magnetic Resonance Image Analysis for Surgeons Using Virtual Reality: A Comparative Study.

Mohamed El Beheiry, Thomas Gaillard, Noémie Girard

|Apr 03, 2021
Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group.

Grégoire Rocher, Thomas Gaillard, Catherine Uzan

Pageof 2

Frequent Collaborators

2 joint publications

Claire Bonneau

2 joint publications

Caroline Malhaire

2 joint publications

Fabien Reyal

2 joint publications

Enora Laas